Skip to main content
Equibles
BBIO $66.75 +0.21%
BBIO logo
BBIO · BridgeBio Pharma, Inc.
Track BBIO — free

Use BBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$66.75 +0.14 (+0.21%)
Russell 1000 member Rebalance outlook locked
Market Cap
$13.37B
Shares
195.49M
All earnings calls

Earnings call · FY2024 Q3

BridgeBio Pharma, Inc. (BBIO) Q3 2024 Earnings Call

Concluded Nov 23, 2024
Nov 23, 2024 0 turns
Period
FY2024 Q3
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $2.73M -33.2% YoY
Diluted EPS -$0.86
Net income -$164.25M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 12, 2024 10-Q report Filed Nov 12, 2024

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License And Service$2.73M
Product$0
Royalty$0
Full-screen source Call document

BBIO transcript alerts

BridgeBio Pharma, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →